Evidence map›Paper›PMID 41510295›Full record

ArticleResearch square2025

Exposure to organochlorine compounds in relation to weight maintenance.

Philippe Grandjean, Alessandra Meddis, Flemming Nielsen, Arne Astrup, Esben Budtz-Jørgensen

Registry-linked trialAbstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00390637 (Diet, Obesity and Genes), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00390637 phase4completednot on this map

Diet, Obesity and Genes

TypeinterventionalSponsorUniversity of CopenhagenRan2006 to 2009Enrolled1,020ConditionsObesity, Metabolic Syndrome, Type 2 Diabetes, Cardiovascular DiseaseArmsHigh or low Glycemic Index and high or low Protein Diet
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Philippe GrandjeanUniversity of Southern Denmark.
Alessandra Meddis
Flemming NielsenSDU.
Arne AstrupNovo Nordisk Foundation.ORCID https://orcid.org/0000-0001-8968-8996
Esben Budtz-Jørgensen

Funding

Sources, Transport, Exposure & Effects of PFAS (STEEP) Center - RENEWALP42ES027706 · NIEHS · UNIVERSITY OF RHODE ISLAND · PI Rainer Lohmann · 2017 to 2026
$18.9M
NIEHS NIH HHS P42 ES027706
6 · The paper itself

Abstract

backgroundThe purpose was to test the hypothesis that exposures to organochlorine compounds are associated with body weight increases in a dietary intervention study.

methodsIn the DioGenes trial, adults with obesity who had at first lost at least 8% of their body weight then completed at least 26 weeks on a specific diet. Concentrations of major organochlorine compounds were assessed in plasma samples obtained at study baseline.

resultsA total of 372 participants with complete data were examined for plasma concentrations of major organochlorine compounds. A doubling in total-PCB in plasma was associated with an increase in weight (in kg) at 26 weeks by 0.43 (0.04;0.83), independent of diet group and sex. Associations for most individual organochlorines were in the same direction, though mostly not statistically significant, especially after adjustment. However,

conclusionsElevated plasma concentrations of some organochlorine compounds were weakly associated with increased weight gain, although most individual associations did not reach statistical significance after adjustment for PFAS exposure. However, p,p'-DDE concentrations showed a clear association with lowered body weight. Overall, the halogenated pollutants examined are likely to contribute to the obesity pandemic.

trial registrationThe original RCT is with ClinicalTrials.gov number NCT00390637.

Indexed as

diet modificationobesogenspolychlorinated hydrocarbonsrandomized clinical trialweight gain

Identifiers

PMID41510295
PMCPMC12776442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.